What is your approach to bladder cancer surveillance in patients who have received cyclophosphamide?

Topics: Bladder Cancer • Rheumatology • Vasculitis • Lupus nephritis • Systemic lupus erythematosus • Cyclophosphamide • Dermatology

Answer from: at Academic Institution

Risk of bladder cancer following cyclophosphamide treatment can be associated with oral therapy and likely also related to cumulative dose (1). Risk of bladder cancer with intermittent IV cyclophosphamide has been reported in some observational studies, but has not been consistently reproduced (2). ...

Comments

at NYU Langone Health
Arguments for intravenous as the preferred route o...

Related Questions